Sana Biotechnology, Inc. (SANA) NASDAQ

3.22

-0.18(-5.29%)

Updated at September 12 04:00PM

Currency In USD

Valuation

Market Cap376.35M
Enterprise Value342.98M
P/E Ratio-3.04
PEG Ratio0.15
Price/Sales Ratio50.04
Price/Book Ratio6.26
Enterprise/Revenue50.97
Enterprise/EBITDA-3.21

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-16.5
Operating Margin-16.9

Management Effectiveness

Return On Assets-0.7
Return On Equity-1.15

Income Statement

Revenue0
Revenue/Share0.06
Gross Profit-15.49M
EBITDA-251.27M
Net Income-266.76M
Diluted EPS-1.16

Balance Sheet

Total Cash72.67M
Total Cash/Share0.3
Total Debt85.49M
Total Debt/Equity0.7
Current Ratio2.47
Book Value Per Share0.51

Price History

52-Week Change-28.92
52-Week High7.3
52-Week Low1.26
Moving Average 50 Days3.72
Moving Average 200 Days2.71

Statistics

Average Volume5.65M
Shares Outstanding237.5M
% Held by Institutions61.04

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A